PMH41 RISPERIDONE LONG ACTING INJECTION (RLAI) IN THE TREATMENT OF EARLY VERSUS LATE DIAGNOSIS PATIENTS WITH SCHIZOPHRENIA- INTERIM RESULTS FROM OBSERVATIONAL STUDIES CONDUCTED IN SPAIN, AUSTRALIA AND BELGIUM

May 1, 2007, 00:00
10.1016/S1098-3015(10)68792-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)68792-X/fulltext
Title : PMH41 RISPERIDONE LONG ACTING INJECTION (RLAI) IN THE TREATMENT OF EARLY VERSUS LATE DIAGNOSIS PATIENTS WITH SCHIZOPHRENIA- INTERIM RESULTS FROM OBSERVATIONAL STUDIES CONDUCTED IN SPAIN, AUSTRALIA AND BELGIUM
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68792-X&doi=10.1016/S1098-3015(10)68792-X
First page :
Section Title :
Open access? : No
Section Order : 580
Categories :
Tags :
Regions :
ViH Article Tags :